Source: http://www.drugtestinfo.com/dot-compliance-2/
Timestamp: 2017-12-18 12:45:22
Document Index: 567575451

Matched Legal Cases: ['art 40', 'art 40', 'art 391', 'art 40', 'art 40', 'art 40']

DOT Compliance — Welcome to NTS
NTS manages collection sites throughout the country. We will customize and match the location of your facility to a nearby collection site. Our team can either set up accounts with your existing sites or locate a closer ones. We make all arrangements to locate convenient sites for each facility location, instruct collection site staff on proper procedures and provide collection supplies. We take responsibility for handling any and all issues regarding the collection of samples.
Specimen collections will be performed by qualified individuals who perform collections in accordance with 49 CFR Part 40, as amended. In order to insure compliance with new collector training requirements, Dr. Taylor has written a collection site training program and used it successfully in collection site training. In addition, the training consists of a collection site training manual which can be downloaded (“DOT Collection Manual”) at our resource center. Collections are available at fixed sites or on-site. Let us know how we can help you.
We will locate and setup the highest quality SAMHSA laboratory with rapid turnaround time that meets your needs. The "gold" standard is a lab which is federally certified by SAMHSA which is the Substance Abuse and Mental Health Services Administration (formerly NIDA, National Institute on Drug Abuse). Dr. Taylor is a SAMSHA laboratory inspector and has previously run a SAMHSA certified laboratory, so he is well aware of the quality issues regarding a laboratory. Since the MRO can have no financial interest in a laboratory according to 49 CFR Part 40, we do not own a laboratory or have any financial interest but subcontract with them as required by federal regulations.
We have multiple in-house Medical Review Officers (MROs) to provide your company with the expertise and service your program deserves. Greg Elam, M.D. and Calvin Channell, M.D. are certified by the American Association of Medical Review Officers. They bring a very professional and personable approach to the review of drug tests.
Complete Random Program Management
DOT physicals are performed by one of our physicians or others qualified to conduct DOT physicals according to 49 CFR Part 391. Our main office is located at 1425 Elm Hill Pike, Nashville, TN 37210. The clinic is walk-in and no appointment is necessary. Hours available for physicals are 8am – 5pm Monday – Friday. In addition, we can review your providers' DOT physicals for compliance.
NTS can help you locate a qualified Substance Abuse Professional (SAP) as defined under 49 CFR Part 40. NTS receives and reviews the information from the Substance Abuse Professional (SAP) and then recommends Return to Duty testing based on the review of the records. If needed, NTS can also provide Return to Work Program Management.
Blind Specimen Submission
The DOT regulations (49 CFR Part 40) require a Quality Assurance/Quality Control Program. Blind Specimens are known quality control samples sent to challenge the laboratory to provide accurate results. To each laboratory to which you send at least 100 specimens in a year you must transmit a number of blind specimens equivalent to 1 percent (1 per 100) you send to that laboratory up to a maximum of 50 Blind specimens in each quarter.
Our blind quality controls are provided by drug free donors or purchased. The blind samples are manufactured to our specifications (usually 2x the screening cutoff), using drug-free human urine. Blind specimens are manufactured from human urine derived from donors screened for Hepatitis and HIV by FDA required testing. Pure drug or their metabolites are added to represent a real donor urine specimen. The Chain of Custody forms are completed by NTS staff to emulate a “real” donor sample. The types of specimens will be submitted in accordance with CFR 49 Part 40 (Approximately 75% Negative, 15% Positive, and 10% Adulterated/Substituted). The number of samples will be prorated based on the number of DOT samples at the rate equivalent to one percent of the specimens sent in to that laboratory, up to a maximum of 50 blind specimens in each quarter. Contact us at sales@drugtestinfo.com.